Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ed, I picked up some WUFG at .05 too
HYVR...CTDH
GETC in and holding :)
Added to HGIIA today at .06
WUFG nice ;)
PWTC looks like it is getting ready to me
Let me know how it looks
PWTC .045 x .05 another chart worth looking at
Bought a while back, been good accumulation going on
SMKT .07 x .075 chart looks great.
I have bought 50k at .06 avg just to let you know
CTDH news:
CTD Holdings Inc. Ships $61,000 in CD Product Orders As Reported by Investor's Business Daily
ORLANDO, Fla., Jan. 29 /PRNewswire-FirstCall/ -- CTD Holdings Inc. (BULLETIN BOARD: CTDH) , a leading provider of cyclodextrins ("CDs") and related products to the food, pharmaceutical and other industries announced today that the company will be featured in Investor's Business Daily this Friday. CTD Holdings recently shipped $61,000 of CD products against $65,000 of orders in the first three weeks of January, 2004. Two of the largest shipments represent the first shipment against blanket orders for the year from two of CTD's largest customers. These most recent customer orders include Alza, Microgenics, Dade Behring, and Sigma Aldrich.
CTD Holdings recently closed its books for its 10K audit; the company announced preliminary financial figures that show record revenues of $169,000 for the 4th quarter while maintaining an 80% gross profit margin.
CTD Holdings will be featured in tomorrow's Investor's Business Daily, and will be featured on http://www.investors.com/ for two weeks.
About Investor's Business Daily
Investor's Business Daily (IBD) was launched in 1984 and is now read by nearly a million investors. It is considered more of a research tool than a traditional newspaper. Known for its innovative stock tables, Investor's Business Daily provides critical information previously available only to institutional investors (pension and mutual funds, banks, insurance companies and government organizations).
About CTD Holdings Inc.:
CTD Holdings Inc. was created to take advantage of the great diversity that cyclodextrins (CDs) bring to new product development. CDs are improving the performance characteristics of products in so many industries that CTDH management decided early on not to chase specific product development tactics, but rather to build expertise in all the areas necessary to develop commercial applications of CDs, whether it was for pharmaceuticals, food products, environmental clean-up, electronics, dietary supplements, OTC medicinals, natural health products, cosmetics, and on, and on. Cyclodextrins are found in many products consumers use everyday such as Procter and Gamble's "Bounce" and "Febreeze".
For investor information contact Matt Maguire at 1 866 THE APPLE or (407) 884-0444
Safe Harbor Act Notice
This release may contain forward-looking statements that involve risks and uncertainties, including without limitation, acceptance of the company's products, increased levels of competition, product and technological changes, the company's dependence upon financing and third-party suppliers, and other risks detailed from time to time in the company's federal filings, annual report, offering memorandum or prospectus. Specifications are subject to change without notice.
CTD Holdings Inc.
CONTACT: Matt Maguire, +1-866-THE-APPLE, or +1-407-884-0444, for CTD
Holdings Inc.
Web site: http://www.cyclodex.com/
CTDH time re-load here at .30 methinks a move is coming.
.07 to .74 back to .30 based here and good volume today. Small float
ASNI .15 x .18 now :))
NGNM .21 x .29 :)
NGNM .21 x .29
CTPI I think it keeps going, breather today
2 steps forward 1 back ;)
Thanks,
I had one of those days where the market was way down but my account balance rose rather nicely
NGNM .15 x .20 (2x1)
NGNM .15 x .20 (2x1)
IYSA .60 x .63
NGNM .12 x .14
Buying NGNM .10 today
NOGN - NeoGenomics, Inc.
Website: http://www.neogenomics.org
http://www.investorshub.com/boards/board.asp?board_id=1333
NeoGenomics, Inc. Announces the Appointment of Thomas H. White as CEO
2004-01-22 12:00 ET - News Release
Also News Release (U-NGNM.OB)
FORT MYERS, Fla., Jan. 22 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (BULLETIN BOARD: NGNM) announced today that Thomas H. White has joined the Company as its Chief Executive Officer.
Mr. White has considerable experience in leading and managing healthcare companies. Most recently, Mr. White was President and Chief Executive Officer of SmartPill Corporation, a biotech company headquarted in Buffalo, NY. SmartPill merged with APPRO Healthcare, Inc. to form SmartPill Diagnostics, Inc. Mr. White remained as Chief Operating Officer until joining NeoGenomics, Inc.
Prior to SmartPill, Mr. White was the President and Chief Executive Officer of ConPharma Home Healthcare, Inc. He lead the turnaround and growth of a 450-employee business, providing home infusion therapy, respiratory, medical equipment and nursing services through 35 locations in the U.S.
Mr. White also held senior management positions with Beverly Enterprises and the Upjohn Company. He has a BBA degree in Marketing and an MBA degree in Business Management and Finance from Western Michigan University.
As Chief Executive Officer for NeoGenomics, Mr. White will be responsible for all business operations, as well as the coordination of the Company's genomic research activities. Michael T. Dent, M.D. will continue as the Company's Chairman, President and Chief Medical Officer.
Dr. Dent, the Company's Chairman stated, "Mr. White brings a wealth of experience and strong business acumen to NeoGenomics. His leadership will contribute greatly towards the growing success of our clinical lab operations and the achievement of our research goals."
Mr. White had the following to say about his appointment, "I'm delighted to be joining NeoGenomics. It is a terrific company that is exceptionally well-poised for rapid growth over the next few years. My initial focus will be on expanding the Company's clinical laboratory operations with new products and increased geographic penetration. We also intend to begin expanding our research initiatives in the near future."
About NeoGenomics, Inc.
NeoGenomics, Inc. has established a state-of-the-art genetic/diagnostic or "Genostics" laboratory in Ft. Myers, FL. The Company's principle operations include providing cytogenetic and molecular biology diagnostic testing services to the oncology and perinatology sectors of the healthcare industry. The Company also conducts research activities for the early diagnosis of women's diseases, such as ovarian cancer, as well as diseases in prenates and infants. For additional information on NeoGenomics, please visit our web site at http://www.neogenomics.org/.
Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to establish its laboratory, develop useful applications from its planned research and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's periodic filings with the SEC.
NeoGenomics, Inc.
CONTACT: Investors, Steven C. Jones of NeoGenomics, +1-239-768-0600, or
sjones@neogenomics.org
Web site: http://www.neogenomics.org/
IYSA .51 x .57 radar it
Buying NGNM .10 today
NOGN - NeoGenomics, Inc.
Website: http://www.neogenomics.org
http://www.investorshub.com/boards/board.asp?board_id=1333
NeoGenomics, Inc. Announces the Appointment of Thomas H. White as CEO
2004-01-22 12:00 ET - News Release
Also News Release (U-NGNM.OB)
FORT MYERS, Fla., Jan. 22 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (BULLETIN BOARD: NGNM) announced today that Thomas H. White has joined the Company as its Chief Executive Officer.
Mr. White has considerable experience in leading and managing healthcare companies. Most recently, Mr. White was President and Chief Executive Officer of SmartPill Corporation, a biotech company headquarted in Buffalo, NY. SmartPill merged with APPRO Healthcare, Inc. to form SmartPill Diagnostics, Inc. Mr. White remained as Chief Operating Officer until joining NeoGenomics, Inc.
Prior to SmartPill, Mr. White was the President and Chief Executive Officer of ConPharma Home Healthcare, Inc. He lead the turnaround and growth of a 450-employee business, providing home infusion therapy, respiratory, medical equipment and nursing services through 35 locations in the U.S.
Mr. White also held senior management positions with Beverly Enterprises and the Upjohn Company. He has a BBA degree in Marketing and an MBA degree in Business Management and Finance from Western Michigan University.
As Chief Executive Officer for NeoGenomics, Mr. White will be responsible for all business operations, as well as the coordination of the Company's genomic research activities. Michael T. Dent, M.D. will continue as the Company's Chairman, President and Chief Medical Officer.
Dr. Dent, the Company's Chairman stated, "Mr. White brings a wealth of experience and strong business acumen to NeoGenomics. His leadership will contribute greatly towards the growing success of our clinical lab operations and the achievement of our research goals."
Mr. White had the following to say about his appointment, "I'm delighted to be joining NeoGenomics. It is a terrific company that is exceptionally well-poised for rapid growth over the next few years. My initial focus will be on expanding the Company's clinical laboratory operations with new products and increased geographic penetration. We also intend to begin expanding our research initiatives in the near future."
About NeoGenomics, Inc.
NeoGenomics, Inc. has established a state-of-the-art genetic/diagnostic or "Genostics" laboratory in Ft. Myers, FL. The Company's principle operations include providing cytogenetic and molecular biology diagnostic testing services to the oncology and perinatology sectors of the healthcare industry. The Company also conducts research activities for the early diagnosis of women's diseases, such as ovarian cancer, as well as diseases in prenates and infants. For additional information on NeoGenomics, please visit our web site at http://www.neogenomics.org/.
Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to establish its laboratory, develop useful applications from its planned research and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's periodic filings with the SEC.
NeoGenomics, Inc.
CONTACT: Investors, Steven C. Jones of NeoGenomics, +1-239-768-0600, or
sjones@neogenomics.org
Web site: http://www.neogenomics.org/
it sure is lol....zip gone
APOA now .105 x .11 :)
CGPN .0073 x .008
ASNI .11 x .15 I wish they were all this easy
ASNI .08 x .09 :)
Buying CGPN .006 nice chart
Buying CGPN at .006 nice chart
Watch APOA at .085 x .095 huge revenues and if lawsuit is settled this could be huge. Market is telling us something here
CTPI buying opp for those not in at .105 today, chart still intact
Still think ZENX .105 x .13 is a great buy and hold, look at the numbers these boys are putting out.
IYSA in at .35 to .46 one to watch
APOA on the move .085 x .09 nice chart, someone has been accumulating for some time now
Lazurus, I think you got the momo boys a bit steamed. Makes for good entertainment hehe
You have been one of the best investor/traders that I have ever met, and I have learned so much from you. You sir, are always welcome to post at the Pennyshac.
Your friend,
Shawn
APOA .073 x .078 getting perky
Ballard Power Systems' AirGen(R) to Provide Backup Power to
NanoSignal's SLICES(TM) Image Processing Workstations
for MRI Systems
NanoSignal Corporation (OTCBB:NNOS) is pleased to announce
agreement with MGE UPS Systems a worldwide distributor and service
provider for Ballard Power Systems' Air Gen(R) fuel cell generators to
purchase Air Gen products through MGE's e-commerce partner, Fuel Cell
Store.com. The AirGen(R) fuel cell generator will provide continuous
backup power for NanoSignal's new SLICES(TM) image processing
workstations used with magnetic resonance imaging (MRI) systems.
The 1-kilowatt AirGen(R) models will be beta-tested at an initial
MRI site operated by Desert Radiology in Las Vegas, Nevada. Upon
successful completion of testing, NanoSignal will include an AirGen(R)
system with each new SLICES workstation. MGE will provide service for
all AirGen(R) units. NanoSignal's unit has been shipped and receipt
anticipated by the end of the week for installation.
NanoSignal's SLICES(TM) technology features groundbreaking
software that manipulates raw data matrices obtained through the MRI
scanning process. Through the use of advanced calculations, SLICES(TM)
systems produce images that boast up to 10 times more clarity and
resolution than standard MRI processing software.
"Ballard's AirGen(R) fuel cell generator is the perfect solution
for MRI applications because of its power conditioning and hours of
backup time," stated Jack Pouchet, director of marketing for MGE UPS
SYSTEMS, INC. Due to the precise nature of MRI scans, these systems
are very susceptible to even the slightest blip in power. The
AirGen(R) provides both line filtering and continuous power in a very
compact and portable design.
According to NanoSignal's engineering team, "We're seeing many
critical applications where traditional battery-based backup systems
are not the ideal solution due to limited backup time, space
constraints and environmental concerns. The AirGen(R) units will
provide NanoSignal's customers with the highest level of power quality
and availability."
The portable AirGen(R) generator, powered with Ballard's Nexa(R)
power module, is easy to operate. Users simply plug electronic
equipment such as the SLICES(TM) workstation or other sensitive
systems directly into the AirGen(R) generator. During a power outage,
the AirGen(R) fuel cell generator will automatically start protecting
connected equipment. Unlike traditional battery backup systems that
last just minutes, the AirGen(R) generator quietly generates
electricity as long as hydrogen fuel is supplied. Ideal for sensitive
electronics, the unit also features built-in surge suppression,
insulating connected equipment from damaging surges and "brown-outs."
MGE supports the AirGen(R) fuel cell generator with its network of
900 service specialists in 170 centers worldwide assuring customer
satisfaction. For more information on the portable AirGen(R)
generator, visit www.fuelcellstore.com or www.mgeups.com/us.
About MGE UPS Systems:
MGE UPS Systems is a world leader in providing high quality power
solutions that increase power availability and system uptime to PCs
and enterprise-wide networks, mission-critical telecommunication
systems, and industrial/manufacturing processes. MGE's comprehensive
product offering includes Uninterruptible Power Supplies (UPSs),
inverters, rectifiers, power management software, active harmonic
conditioner, and surge suppressors that provide MGE's customers with
end-to-end infrastructure solutions. With its Total Quality Management
and MGE Power Services programs, supported by a network of 900 service
specialists in 170 centers worldwide, MGE's customers are assured of
the highest-level of quality and service throughout the complete life
cycle of their installations.
With U.S. headquarters in Costa Mesa, California, MGE is able to
deliver the latest in innovative solutions round the globe. To learn
more about MGE's power protection, conversion and distribution
solutions, visit MGE's Web site at www.mgeups.com.
About FuelCellStore.com:
FuelCellStore.com, based in Colorado, is a leading global
distributor of fuel cell products. The company is one of the first
online portals dedicated to offering commercially available fuel cell
systems and associated products directly to consumers. More than 100
companies from around the world are now working with FueCellStore.com
to bring their products to the global marketplace.
About Ballard Power Systems:
Ballard Power Systems is recognized as the world leader in
developing, manufacturing and marketing zero-emission proton exchange
membrane fuel cells. Ballard is commercializing fuel cell engines for
transportation applications and fuel cell systems for portable and
stationary products. Ballard is also commercializing electric drives
for fuel cell and other electric vehicles and power conversion
products, and is a Tier 1 automotive supplier of friction materials
for power train components. Ballard's proprietary technology is
enabling automobile, bus, electrical equipment, portable power and
stationary product manufacturers to develop environmentally clean
products for sale. Ballard is partnering with strong, world-leading
companies, including DaimlerChrysler, Ford, EBARA, ALSTOM an
FirstEnergy, to commercialize Ballard(R) fuel cells. Ballard has
supplied fuel cells to Honda, MGE UPS SYSTEMS, Mitsubishi, Nissan, and
Volkswagen, among others.
This press release contains "forward-looking statements" within
the meaning of Private Securities Litigation Reform Act of 1995. Such
statements can be identified by lead-in "Looking Forward". These
statements are not guarantees of future performance and involve
significant risks and uncertainties. Actual results may vary
materially from those in the forward-looking statements as a result of
the effectiveness of management's strategies and decisions, general
economic and business conditions, new or modified statutory or
regulatory requirements, and changing price and market conditions. No
assurance can be given that these are all the factors that could cause
actual results to vary materially from the forward-looking statement.
Contacts:
Princeton Research, Inc.
Michael King, 702-650-3000
NanoSignal Corporation Announces Agreements With Dr. Jeffery Taft as Technical and Scientific Consultant
2004-01-26 21:21 ET - News Release
LAS VEGAS -- (Business Wire) -- Jan. 26, 2004
NanoSignal Corporation (OTCBB:NNOS) (formerly
MicroSignal Corporation), Dr. Lawrence Madoff, CEO of NanoSignal
Corporation is pleased to announce a definitive agreement with Dr.
Jeffery Taft to join NanoSignal Corporation as technical and
scientific consultant.
Dr. Taft is a physicist/mathematician, an inventor of SLICES(TM)
Technology, and a founding member of former MicroSignal Corporation.
Dr. Taft will advise our team of engineers and offer assistance in the
installation of the SLICES(TM) units. With his addition to our team,
NanoSignal Corporation is ready to pursue new and exciting
applications of its technology (e.g. early detection of stroke)
cerebral blood flow and coronary artery blood flow are potential areas
that show promise using NanoSignal Technology.
For further information please visit our website
www.nanosignalcorp.com.
This press release contains "forward-looking statements" within
the meaning of Private Securities Litigation Reform Act of 1995. Such
statements can be identified by lead-in "Looking Forward." These
statements are not guarantees of future performance and involve
significant risks and uncertainties. Actual results may vary
materially from those in the forward-looking statements as a result of
the effectiveness of management's strategies and decisions, general
economic and business conditions, new or modified statutory or
regulatory requirements, and changing price and market conditions. No
assurance can be given that these are all the factors that could cause
actual results to vary materially from the forward-looking statement.
Contacts:
Princeton Research, Inc.
Michael King, 702-650-3000